methysergide has been researched along with ici 170809 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, T; Edvinsson, L; Eriksen, K; Jansen, I | 1 |
| Frenken, M; Kaumann, AJ | 1 |
2 other study(ies) available for methysergide and ici 170809
| Article | Year |
|---|---|
5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries.
Topics: Cerebral Arteries; Humans; In Vitro Techniques; Methysergide; Muscle, Smooth, Vascular; Quinolines; Receptors, Serotonin; Serotonin Antagonists; Temporal Arteries; Vasoconstriction | 1991 |
Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
Topics: Animals; Cattle; Dose-Response Relationship, Drug; In Vitro Techniques; Methylation; Methysergide; Quinolines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Vasoconstriction | 1989 |